Scholars Central

Research articlePublished 17 Dec 1998

Glutamate Antagonists, Steroids, andAntioxidants as Therapeutic Options forHearing Loss and Tinnitus and the Use ofan Inner Ear Drug Delivery System

Authors: Michael D. Seidman

The International Tinnitus Journal

Volume 4 · Issue 2 · Pages 148–154

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A wealth of anecdotal, empirical, and double-blind, placebo-controlled data exists on medicines that may have a beneficial role in the management of patients with tinnitus. Tinnitus is a symptom that affects between 40 and 45 million Americans alone; this represents approximately 14% of the US population. Data exist for Japan (popUlation: 125,732,794), Europe (population: 503 million), and Australia (population: 18,426,900), and estimates suggest that tinnitus affects a similar percentage of those populations (B. Tabachnick, personal communication, 1998). Thus, in those industrialized nations, approximately 90 million may experience tinnitus to some degree. One to two percent of the population experiences debilitating tinnitus, severely limiting the quality of life of affected individuals. All too often, the response from well-trained medical professionals is, "Learn to live with it" or "There is no cure." Although the author does not dispute that currently no cure exists, I contend that help is available. This article discusses the use of glutamate antagonists, steroids, and antioxidants for the management of hearing loss and tinnitus. Additionally, the results of using an inner ear drug delivery system on nine patients with a variety of inner ear disorders are reviewed briefly.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalThe International Tinnitus Journal
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Michael D. Seidman”